JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5976
Peoples Bancorp of North Carolina
PEBK
$230M
| $22.5K | ﹤0.01% |
+744
| New | +$18.7K |
2023 Q4
0 quarters
|
|
|
MHN
5977
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $22.4K | ﹤0.01% |
2,131
-404
| -16% | -$3.9K |
2023 Q1
3 quarters
|
|
|
LRFC
5978
DELISTED
Logan Ridge Finance Corp
LRFC
| $22.3K | ﹤0.01% |
1,000
| – | – |
2023 Q2
2 quarters
|
|
|
EGIO
5979
DELISTED
Edgio, Inc. Common Stock
EGIO
| $21.9K | ﹤0.01% |
1,600
+68
| +4% | +$1.68K |
2016 Q4
28 quarters
|
|
|
ROSS.WS
5980
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
| – | – |
0
| – | – |
2021 Q3
9 quarters
|
|
|
GCV
5981
Gabelli Convertible and Income Securities Fund
GCV
$82.6M
| $21.7K | ﹤0.01% |
6,023
-2,325
| -28% | -$8.18K |
2023 Q3
1 quarter
|
|
|
ZTEK
5982
DELISTED
Zentek
ZTEK
| $21.6K | ﹤0.01% |
20,000
| – | – |
2023 Q3
1 quarter
|
|
5983
SenesTech
SNES
$3.63M
| $21.6K | ﹤0.01% |
+1,697
| New | +$44.7K |
2023 Q4
0 quarters
|
|
5984
T. Rowe Price QM US Bond ETF
TAGG
$2.6B
| $21.5K | ﹤0.01% |
+500
| New | +$20.6K |
2023 Q4
0 quarters
|
|
5985
AC Immune
ACIU
$279M
| $21.4K | ﹤0.01% |
4,278
+3,078
| +257% | +$9.89K |
2020 Q4
12 quarters
|
|
|
WHWK
5986
Whitehawk Therapeutics
WHWK
$214M
| $21.3K | ﹤0.01% |
10,548
| – | – |
2022 Q2
6 quarters
|
|
|
IA
5987
Innovative Solutions & Support
IA
$333M
| $21.3K | ﹤0.01% |
2,496
+1,461
| +141% | +$11.1K |
2023 Q3
1 quarter
|
|
5988
Innovator US Equity Ultra Buffer ETF January
UJAN
$254M
| $21.2K | ﹤0.01% |
616
-3,248
| -84% | -$109K |
2023 Q2
2 quarters
|
|
|
SWZ
5989
Swiss Helvetia Fund
SWZ
$74.2M
| $21.2K | ﹤0.01% |
2,581
-3,717
| -59% | -$28.3K |
2015 Q4
32 quarters
|
|
5990
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$347M
| $21.1K | ﹤0.01% |
699
+219
| +46% | +$8.21K |
2022 Q4
4 quarters
|
|
|
RVNC
5991
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $21.1K | ﹤0.01% |
2,400
| – | – |
2023 Q3
1 quarter
|
|
5992
Nuveen Core Plus Impact Fund
NPCT
$264M
| $21.1K | ﹤0.01% |
+2,092
| New | +$19.9K |
2023 Q4
0 quarters
|
|
5993
Karooooo
KARO
$1.88B
| $21K | ﹤0.01% |
864
-1,081
| -56% | -$25.9K |
2023 Q3
1 quarter
|
|
|
RAIN
5994
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $20.7K | ﹤0.01% |
17,220
+5,753
| +50% | +$6.21K |
2021 Q2
10 quarters
|
|
5995
Southland Holdings
SLND
$36.4M
| $20.5K | ﹤0.01% |
3,977
+1,542
| +63% | +$8.86K |
2023 Q2
2 quarters
|
|
5996
FreightCar America
RAIL
$215M
| $20.3K | ﹤0.01% |
7,520
+7
| +0.1% | +$18 |
2022 Q2
6 quarters
|
|
|
JOBY.WS
5997
DELISTED
Joby Aviation Warrants
JOBY.WS
| – | – |
0
| – | – |
2021 Q4
8 quarters
|
|
5998
Telecom Argentina
TEO
$5.02B
| $19.8K | ﹤0.01% |
2,772
-1,217
| -31% | -$7.8K |
2023 Q3
1 quarter
|
|
5999
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$602M
| $19.7K | ﹤0.01% |
175
+1
| +0.6% | +$103 |
2022 Q4
4 quarters
|
|
|
MRCC
6000
DELISTED
Monroe Capital Corp
MRCC
| $19.7K | ﹤0.01% |
+2,787
| New | +$19.8K |
2023 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.